Share chart Spectral Medical Inc.
Extended chart
Simple chart
About Spectral Medical Inc.
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. more details| ISIN | CA8475771033 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | cad |
| Див.доход ао | 57.14 |
| Дивиденд ао | 0.12 |
| Сайт | https://spectraldx.com |
| Цена ао | 0.467 |
| Change price per day: | +3.85% (0.467) |
|---|---|
| Change price per week: | -2.41% (0.497) |
| Change price per month: | +15.75% (0.419) |
| Change price per 3 month: | +38.57% (0.35) |
| Change price per half year: | -3% (0.5) |
| Change price per year: | +54.85% (0.3132) |
| Change price per 3 year: | +74.46% (0.278) |
| Change price per 5 year: | -13.39% (0.56) |
| Change price per 10 year: | 0% (0.485) |
| Change price per year to date: | +50.62% (0.322) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Benedetti & Gucer, Inc. | 22200 | 0.01 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Christopher Seto | CEO, CFO & Director | 351.22k | |
| Dr. John A. Kellum M.D. | Chief Medical Officer | 325.75k |
Address: Canada, Toronto, 135 The West Mall - open in Google maps, open in Yandex maps
Website: https://spectraldx.com
Website: https://spectraldx.com
